Citations

Mayo Clinic

Showing 10 of 108522 citations.

Steatorrhea Complicating Diabetes Mellitus with Neuropathy: Report of Cases without Apparent External Pancreatic Insufficiency
Berge, Kenneth G., Wollaeger, Eric E., Scholz, D, Rooke, E. Douglas , Sprague, Randall G.

Diabetes | December 11, 2014 | Volume: 5 | Issue: 1 | Pages: 25-31

10.2337/diab.5.1.25 | PMID 13294004 Get It

Disturbances of gastrointestinal function have frequently been observed in association with diabetes mellitus. The disorders which have been reported include gastric atony and dilatation, postprandial abdominal cramping, severe constipation, and intractable diarrhea characterized by watery stools, nocturnal exacerbations and fecal incontinence. These disturbances have been attributed by many investigators to alterations in gastrointestinal motility secondary to visceral diabetic neuropathy. The purpose of the present report is to call attention to a group of patients with diabetes mellitus and neuropathy who exhibited diarrhea and steatorrhea which apparently could not be attributed to external pancreatic insufficiency.
Karl Petrén: A Leader in Pre-Insulin Dietary Therapy of Diabetes
Wilder, Russell M.

Diabetes | December 11, 2014 | Volume: 4 | Issue: 2 | Pages: 159-160

10.2337/diab.4.2.159 | PMID 14380097 Get It

Neurologic Complications Associated with Diabetes
Bailey, Allan A., BAILEY, A A

Diabetes | December 11, 2014 | Volume: 4 | Issue: 1 | Pages: 32-36

10.2337/diab.4.1.32 | PMID 14365548 Get It

The Effects of Adrenalectomy and of Hypophysectomy on the Degenerative Complications of Diabetes
Sprague, Randall G.

Diabetes | December 11, 2014 | Volume: 3 | Issue: 5 | Pages: 411-412

10.2337/diab.3.5.411 | PMID 13220444 Get It

Diabetes Mellitus and Cushing's Syndrome: Concentrations of Lactate and Pyruvate in Blood After Ingestion of Glucose
Hills, O.W., Power, Marschelle H., Wilder, Russell M.

Diabetes | December 11, 2014 | Volume: 1 | Issue: 5 | Pages: 351-357

10.2337/diab.1.5.351 | PMID 12979981 Get It

The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity
Kuhn, Peer‐Hendrik , Laurent, Sarah , Hauck, Stefanie M. , Berer, Kerstin, Wendlinger, Simone A., Krumbholz, Markus , Khademi, Mohsen , Olsson, Tomas , Dreyling, Martin , Pfister, H.-W., Alexander, Tobias , Hiepe, Falk , Kümpfel, Tania , Wekerle, Hartmut , Hohlfeld, Reinhard , Meinl, Edgar , Crawford, Howard C, Hoffmann, Franziska S. , Crawford, Howard C. , Lichtenthaler, Stefan F.

The Journal of Immunology | December 11, 2014 | Volume: 194 | Issue: 2 | Pages: 542-552

10.4049/jimmunol.1402070 | PMID 25505277 Get It

Abstract BAFF and a proliferation-inducing ligand (APRIL), which control B cell homeostasis, are therapeutic targets in autoimmune diseases. TACI-Fc (atacicept), a soluble fusion protein containing the extracellular domain of the BAFF–APRIL receptor TACI, was applied in clinical trials. However, disease activity in multiple sclerosis unexpectedly increased, whereas in systemic lupus erythematosus, atacicept was beneficial. In this study, we show that an endogenous soluble TACI (sTACI) exists in vivo. TACI proteolysis involved shedding by a disintegrin and metalloproteinase 10 releasing sTACI from activated B cells. The membrane-bound stub was subsequently cleaved by γ-secretase reducing ligand-independent signaling of the remaining C-terminal fragment. The shed ectodomain assembled ligand independently in a homotypic way. It functioned as a decoy receptor inhibiting BAFF- and APRIL-mediated B cell survival and NF-κB activation. We determined sTACI levels in autoimmune diseases with established hyperactivation of the BAFF–APRIL system. sTACI levels were elevated both in the cerebrospinal fluid of the brain-restricted autoimmune disease multiple sclerosis correlating with intrathecal IgG production, as well as in the serum of the systemic autoimmune disease systemic lupus erythematosus correlating with disease activity. Together, we show that TACI is sequentially processed by a disintegrin and metalloproteinase 10 and γ-secretase. The released sTACI is an immunoregulator that shares decoy functions with atacicept. It reflects systemic and compartmentalized B cell accumulation and activation.
Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability
Service, F. John, Molnar, George D., Rosevear, John W., Ackerman, Eugene, Gatewood, Laël C., Taylor, William F.

Diabetes | December 11, 2014 | Volume: 19 | Issue: 9 | Pages: 644-655

10.2337/diab.19.9.644 | PMID 5469118 Get It

Three normal, three stable diabetic, and eight unstable diabetic subjects were investigated, with continuous automated blood glucose analysis for forty-eight-hour periods, during metabolic balance studies of six days' duration under near normal conditions (fed and ambulatory) after the attainment of clinically optimal diabetic regulation. The studies on unstable diabetics were performed during constant dietary intake, with one or two daily injections of intermediate-acting insulin and then repeated with four daily injections of short-acting insulin. A characteristic of blood glucose behavior, the mean amplitude of glycemic excursion (MAGE), was measured. MAGE was small for normals (range, 22 to 60 mg./100 ml.), larger for stable diabetics (67 to 82 mg./100 ml.), and largest for unstable diabetics (119 to 200 mg./100 ml.). Associated with a significant decrease (p = 0.004) in the mean diurnal glycemic level (from 146 to 244 mg,/100 ml. to 101 to 152 mg./100 ml.) achieved through the use of four daily doses of short-acting insulin there was a significant increase (p = 0.006) in hypoglycemic episodes (from 0 to 4/48 hr. to 3 to 6/48 hr.) without significant change in MAGE. The persistently large value of MAGE despite therapy with multiple injections of short-acting insulin appears to be a characteristic of unstable diabetes.
Sex-Specific Associations of Established and Emerging Cardiac Biomarkers with All-Cause Mortality in Older Adults: The ActiFE Study
Dallmeier, Dhayana , Denkinger, Michael , Peter, Richard , Rapp, Kilian , Jaffe, Allan S. , Köenig, Wolfgang , Group, for the ActiFE Study, Rothenbacher, Dietrich, Jaffe, Allan S. , Group, for the ActiFE Study, Rothenbacher, Dietrich, Koenig, Wolfgang

Clinical Chemistry | December 11, 2014 | Volume: 61 | Issue: 2 | Pages: 389-399

10.1373/clinchem.2014.230839 | PMID 25501933 Get It

Abstract BACKGROUND N-terminal pro B-type natriuretic peptide (NT-proBNP) has strong prognostic value for all-cause mortality in the general population. High-sensitivity assays now allow detection of cardiac troponins even in asymptomatic populations. We examined the association between NT-proBNP, high-sensitivity cardiac troponin T (hs-cTnT), and hs-cTnI and all-cause mortality in older adults. METHODS We conducted a longitudinal cohort study [Activity and Function in the Elderly in Ulm (ActiFE Ulm)] including 1506 community-dwelling adults ≥65 years old with NT-proBNP, hs-cTnT, and hs-cTnI measured at baseline. We evaluated the associations between log-transformed biomarker concentrations and 4-year total mortality, accounting for possible confounders, with Cox proportional hazards models. RESULTS We observed 125 deaths among 1422 participants (median follow-up 4 years). We detected effect modification by sex for all biomarkers (all P values <0.05) expressed as hazard ratio (HR) for death per 1-unit increment of ln(biomarker concentration) in women (n = 618, 37 deaths) compared with men (n = 804, 88 deaths): HR 2.97 (95% CI 2.04–4.33) vs 1.73 (1.40–2.13) for NT-proBNP; 3.67 (2.31–5.81) vs 2.15 (1.61–2.87) for hs-cTnT; and 3.32 (2.13–5.18) vs 1.92 (1.55–2.38) for hs-cTnI. Among 777 participants with undetectable hs-cTnT (<5 ng/L), hs-cTnI remained associated with all-cause mortality in age- and sex-adjusted analysis. CONCLUSIONS NT-proBNP, hs-cTnT, and hs-cTnI were independently associated with all-cause mortality in older adults. The strength of these associations varied between men and women, emphasizing the need for additional sex-specific research among older people.
Effects of hydration in rats and mice with polycystic kidney disease
Ye, Hong , Irazabal, María V. , Harris, Peter C. , Torres, Vicente E. , Hopp, Katharina , Wang, Xiaofang , Harris, Peter C , Torres, Vicente E , Irazabal, Maria V

American Journal of Physiology-Renal Physiology | December 10, 2014 | Volume: 308 | Issue: 3 | Pages: F261-F266

10.1152/ajprenal.00345.2014 | PMID 25503729 Get It

Vasopressin and V2 receptor signaling promote polycystic kidney disease (PKD) progression, raising the question whether suppression of vasopressin release through enhanced hydration can delay disease advancement. Enhanced hydration by adding 5% glucose to the drinking water has proven protective in a rat model orthologous to autosomal recessive PKD. We wanted to exclude a glucose effect and explore the influence of enhanced hydration in a mouse model orthologous to autosomal dominant PKD. PCK rats were assigned to normal water intake (NWI) or high water intake (HWI) groups achieved by feeding a hydrated agar diet (HWI-agar) or by adding 5% glucose to the drinking water (HWI-glucose), with the latter group used to recapitulate previously published results. Homozygous Pkd1 R3277C ( Pkd1RC/RC) mice were assigned to NWI and HWI-agar groups. To evaluate the effectiveness of HWI, kidney weight and histomorphometry were assessed, and urine vasopressin, renal cAMP levels, and phosphodiesterase activities were measured. HWI-agar, like HWI-glucose, reduced urine vasopressin, renal cAMP levels, and PKD severity in PCK rats but not in Pkd1RC/RC mice. Compared with rat kidneys, mouse kidneys had higher phosphodiesterase activity and lower cAMP levels and were less sensitive to the cystogenic effect of 1-deamino-8-d-arginine vasopressin, as previously shown for Pkd1RC/RC mice and confirmed here in Pkd2WS25/− mice. We conclude that the effect of enhanced hydration in rat and mouse models of PKD differs. More powerful suppression of V2 receptor-mediated signaling than achievable by enhanced hydration alone may be necessary to affect the development of PKD in mouse models.